Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
Hepatology Communications|June 18, 2021
Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH StudyA Sidney Barritt, Stephanie Watkins, Norman Gitlin, et al.
Gastroenterology|October 4, 2021
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver DiseaseFasiha Kanwal, Jay H Shubrook, Leon A Adams, et al.
Diabetes Care|December 23, 2020
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic ScreeningRomina Lomonaco, Eddison Godinez Leiva, Fernando Bril, et al.
The Lancet Regional Health. Europe|July 17, 2025
A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitisJeffrey V Lazarus, Paul N Brennan, Henry E Mark, et al.
Diabetologia|September 24, 2025
Pancreatic cancer-related diabetes and type 2 diabetes differ in multiple aspects of glucose homeostasisFrederico G S Toledo, Yisheng Li, Fuchenchu Wang, et al.
Clinics in Liver Disease|April 6, 2023
Research Priorities for Precision Medicine in NAFLDPaula Iruzubieta, Ramon Bataller, María Teresa Arias-Loste, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2025
Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' PerspectiveZobair M Younossi, Homie Razavi, Michael Sherman, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2022
Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLDSrilaxmi Kalavalapalli, Eddison Godinez Leiva, Romina Lomonaco, et al.
Diabetes Care|May 28, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes AssociationKenneth Cusi, Manal F Abdelmalek, Caroline M Apovian, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2022
A Reduced Pancreatic Polypeptide Response is Associated With New-onset Pancreatogenic Diabetes Versus Type 2 DiabetesPhil A Hart, Yogish C Kudva, Dhiraj Yadav, et al.
Pageof 19